Production and characterization of impurities in isoflurane vaporizers

S. T. Weldon, S. I. Williams-Van Alstyne, A Jay Gandolfi, C. D. Blitt

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Unwanted substances in hydrogenated anesthetics have been reported occasionally. Raventos and Lemon and Torkelson et al. characterized the toxicity of undesirable compounds found in halothane and methoxyflurane during their industrial synthesis. Their investigations led to an awareness of the possible impurities in anesthetics and steps were taken to improve the synthesis and stabilize the halogenated anesthetics. Current commercially available anesthetics are reported to contain less than .0075% wt/wt or less than 75 ppm impurities. In a study by Sharp et al., the breakdown of halothane during closed-circuit anesthesia was examined. The degradation was found to be due to the interaction of halothane with soda lime in the filtering unit. The product of this degradation, 2-bromo-2-chloro-1,1-difluorethylene is toxic. However, toxic concentrations did not accumulate during open- or closed circuit anesthesia. In 1981 Wald described two instances of the presence of yellow 'impurities' in enflurane in an Ohio calibrated vaporizer. Wald felt that the impurities were not from the degradation of enflurane, but from a 'sulfurous' component in the vaporizer wick. In 1982 we observed a yellowish discoloration in isoflurane in an Ohio calibrated vaporizer. Preliminary studies by our laboratory found that these impurities were not 'sulfurous paper components' but were organic in nature. This report characterizes the impurities in isoflurane vaporizers, determines their origin, and performs field analyses to determine the magnitude of the problem.

Original languageEnglish (US)
Pages (from-to)634-639
Number of pages6
JournalAnesthesia and Analgesia
Volume64
Issue number6
StatePublished - 1985

Fingerprint

Nebulizers and Vaporizers
Isoflurane
Anesthetics
Closed-Circuit Anesthesia
Halothane
Enflurane
Poisons
Capillary Action
Methoxyflurane

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Weldon, S. T., Williams-Van Alstyne, S. I., Gandolfi, A. J., & Blitt, C. D. (1985). Production and characterization of impurities in isoflurane vaporizers. Anesthesia and Analgesia, 64(6), 634-639.

Production and characterization of impurities in isoflurane vaporizers. / Weldon, S. T.; Williams-Van Alstyne, S. I.; Gandolfi, A Jay; Blitt, C. D.

In: Anesthesia and Analgesia, Vol. 64, No. 6, 1985, p. 634-639.

Research output: Contribution to journalArticle

Weldon, ST, Williams-Van Alstyne, SI, Gandolfi, AJ & Blitt, CD 1985, 'Production and characterization of impurities in isoflurane vaporizers', Anesthesia and Analgesia, vol. 64, no. 6, pp. 634-639.
Weldon, S. T. ; Williams-Van Alstyne, S. I. ; Gandolfi, A Jay ; Blitt, C. D. / Production and characterization of impurities in isoflurane vaporizers. In: Anesthesia and Analgesia. 1985 ; Vol. 64, No. 6. pp. 634-639.
@article{d9eb202d53f3475cbdcc5f14e9cf3c84,
title = "Production and characterization of impurities in isoflurane vaporizers",
abstract = "Unwanted substances in hydrogenated anesthetics have been reported occasionally. Raventos and Lemon and Torkelson et al. characterized the toxicity of undesirable compounds found in halothane and methoxyflurane during their industrial synthesis. Their investigations led to an awareness of the possible impurities in anesthetics and steps were taken to improve the synthesis and stabilize the halogenated anesthetics. Current commercially available anesthetics are reported to contain less than .0075{\%} wt/wt or less than 75 ppm impurities. In a study by Sharp et al., the breakdown of halothane during closed-circuit anesthesia was examined. The degradation was found to be due to the interaction of halothane with soda lime in the filtering unit. The product of this degradation, 2-bromo-2-chloro-1,1-difluorethylene is toxic. However, toxic concentrations did not accumulate during open- or closed circuit anesthesia. In 1981 Wald described two instances of the presence of yellow 'impurities' in enflurane in an Ohio calibrated vaporizer. Wald felt that the impurities were not from the degradation of enflurane, but from a 'sulfurous' component in the vaporizer wick. In 1982 we observed a yellowish discoloration in isoflurane in an Ohio calibrated vaporizer. Preliminary studies by our laboratory found that these impurities were not 'sulfurous paper components' but were organic in nature. This report characterizes the impurities in isoflurane vaporizers, determines their origin, and performs field analyses to determine the magnitude of the problem.",
author = "Weldon, {S. T.} and {Williams-Van Alstyne}, {S. I.} and Gandolfi, {A Jay} and Blitt, {C. D.}",
year = "1985",
language = "English (US)",
volume = "64",
pages = "634--639",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Production and characterization of impurities in isoflurane vaporizers

AU - Weldon, S. T.

AU - Williams-Van Alstyne, S. I.

AU - Gandolfi, A Jay

AU - Blitt, C. D.

PY - 1985

Y1 - 1985

N2 - Unwanted substances in hydrogenated anesthetics have been reported occasionally. Raventos and Lemon and Torkelson et al. characterized the toxicity of undesirable compounds found in halothane and methoxyflurane during their industrial synthesis. Their investigations led to an awareness of the possible impurities in anesthetics and steps were taken to improve the synthesis and stabilize the halogenated anesthetics. Current commercially available anesthetics are reported to contain less than .0075% wt/wt or less than 75 ppm impurities. In a study by Sharp et al., the breakdown of halothane during closed-circuit anesthesia was examined. The degradation was found to be due to the interaction of halothane with soda lime in the filtering unit. The product of this degradation, 2-bromo-2-chloro-1,1-difluorethylene is toxic. However, toxic concentrations did not accumulate during open- or closed circuit anesthesia. In 1981 Wald described two instances of the presence of yellow 'impurities' in enflurane in an Ohio calibrated vaporizer. Wald felt that the impurities were not from the degradation of enflurane, but from a 'sulfurous' component in the vaporizer wick. In 1982 we observed a yellowish discoloration in isoflurane in an Ohio calibrated vaporizer. Preliminary studies by our laboratory found that these impurities were not 'sulfurous paper components' but were organic in nature. This report characterizes the impurities in isoflurane vaporizers, determines their origin, and performs field analyses to determine the magnitude of the problem.

AB - Unwanted substances in hydrogenated anesthetics have been reported occasionally. Raventos and Lemon and Torkelson et al. characterized the toxicity of undesirable compounds found in halothane and methoxyflurane during their industrial synthesis. Their investigations led to an awareness of the possible impurities in anesthetics and steps were taken to improve the synthesis and stabilize the halogenated anesthetics. Current commercially available anesthetics are reported to contain less than .0075% wt/wt or less than 75 ppm impurities. In a study by Sharp et al., the breakdown of halothane during closed-circuit anesthesia was examined. The degradation was found to be due to the interaction of halothane with soda lime in the filtering unit. The product of this degradation, 2-bromo-2-chloro-1,1-difluorethylene is toxic. However, toxic concentrations did not accumulate during open- or closed circuit anesthesia. In 1981 Wald described two instances of the presence of yellow 'impurities' in enflurane in an Ohio calibrated vaporizer. Wald felt that the impurities were not from the degradation of enflurane, but from a 'sulfurous' component in the vaporizer wick. In 1982 we observed a yellowish discoloration in isoflurane in an Ohio calibrated vaporizer. Preliminary studies by our laboratory found that these impurities were not 'sulfurous paper components' but were organic in nature. This report characterizes the impurities in isoflurane vaporizers, determines their origin, and performs field analyses to determine the magnitude of the problem.

UR - http://www.scopus.com/inward/record.url?scp=0022415212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022415212&partnerID=8YFLogxK

M3 - Article

C2 - 4003780

AN - SCOPUS:0022415212

VL - 64

SP - 634

EP - 639

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 6

ER -